NCT03302845View on ClinicalTrials.gov

A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

October 23, 2017

Study Completion Date

November 7, 2017

Conditions
Drug-drug Interaction
Interventions
DRUG

Omeprazole 40 MG

Omeprazole 40 mg capsule

DRUG

Famotidine 40 mg

Famotidine 40 mg tablet

DRUG

Telotristat ethyl 250 mg

Telotristat ethyl 250 mg tablet

Trial Locations (1)

75247

Covance Clinical Research Unit, Dallas

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY